Skip to main content
Cloudbreak Pharma Inc. logo

Cloudbreak Pharma Inc. — Investor Relations & Filings

Ticker · 2592 HKEX Manufacturing
Open in API
Filings indexed 71 across all filing types
Latest filing 2026-02-04 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2592

About Cloudbreak Pharma Inc.

https://cloudbreakpharma.com/

Cloudbreak Pharma Inc. is an innovative, clinical-stage ophthalmology biotechnology company dedicated to the research and development of novel and differentiated treatments for chronic eye diseases. The company focuses on improving vision quality globally by developing therapies for both anterior and posterior segment ophthalmic conditions. Its robust pipeline includes products targeting pterygium, pinguecula, meibomian gland dysfunction, glaucoma filtration surgery, age-related macular degeneration, and diabetic retinopathy. Cloudbreak utilizes advanced platforms, including a potent multi-kinase inhibitor formulated as a topical eye drop for anterior segment diseases and a unique Antibody-Drug Synergism Platform for posterior segment diseases.

Recent filings

Filing Released Lang Actions
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Stock Exchange. It details movements in securities, including changes in issued shares, share options, and public float sufficiency. This type of filing is a standard regulatory requirement for companies listed on the HKEX to report monthly changes in their share capital and is classified under the 'Share Issue/Capital Change' category.
2026-02-04 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited. This is a standard regulatory filing required by the HKEX Listing Rules to report movements in securities, share capital, and treasury shares on a monthly basis. It does not represent a specific corporate event like an earnings release, dividend announcement, or M&A activity, but rather a recurring regulatory disclosure of share capital structure. Therefore, it falls under the 'Regulatory Filings' category.
2026-02-04 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited. This is a standard regulatory filing required by the HKEX for listed companies to report movements in securities, share capital, and share options on a monthly basis. It does not fit into specific categories like 10-K, Earnings Release, or M&A, and is not a simple announcement of a report, but rather a mandatory regulatory disclosure form. Therefore, it is classified as a Regulatory Filing (RNS).
2026-02-04 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited. This is a standard regulatory filing required by the HKEX for listed companies to report movements in their securities, share capital, and public float. It does not represent a financial report, dividend announcement, or management change, but rather a recurring regulatory disclosure of share capital status. Therefore, it falls under the 'Regulatory Filings' category.
2026-02-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, share options, and other equity changes. It does not fit into specific categories like 'Earnings Release' or 'Annual Report' as it is a recurring regulatory compliance filing regarding share capital structure. Therefore, it is classified as a Regulatory Filing (RNS).
2026-02-02 English
INSIDE INFORMATION ANNOUNCEMENT - UPDATE IN RELATION TO SETTLEMENT OF PROCEEDINGS
Legal Proceedings Report Classification · 1% confidence The document is an 'Inside Information Announcement' regarding the settlement of legal proceedings and the lifting of an asset preservation order. It references previous announcements and provides a status update on legal matters involving the company. Since it specifically details the resolution of legal proceedings and court rulings, it falls under the 'Legal Proceedings Report' category.
2026-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.